WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Tuesday, September 19, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email


Drug Delivery in Cancer Technologies, Markets and Companies 2016-2026
Wednesday, September 13, 2017

DUBLIN, September 13, 2017 /PRNewswire/ --

The "Drug Delivery in Cancer - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also prevent damage to normal tissues and prevent drug resistance.

Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors, antisense approaches, gene therapy and combination of various methods. Important methods of immunotherapy in cancer involve use of cytokines, monoclonal antibodies, cancer vaccines and immunogene therapy.

Several innovative methods of drug delivery are used in cancer. These include use of microparticles as carriers of anticancer agents. These may be injected into the arterial circulation and guided to the tumor by magnetic field for targeted drug delivery. Polyethylene glycol (PEG) technology has been used to overcome some of the barriers to anticancer drug delivery. Encapsulating anticancer drugs in liposomes enables targeted drug delivery to tumor tissues and prevents damage to the normal surrounding tissues. Monoclonal antibodies can be used for the delivery of anticancer payloads such as radionucleotides, toxins and chemotherapeutic agents to the tumors.

Antisense oligonucleotides have been in clinical trials for cancer for some time now. RNAi has also been applied in oncology. Small interfering RNAs (siRNAs) can be targeted to tumors and one example is suppression of H-ras gene expression indicating the potential for application in therapy of ovarian cancer. Cancer gene therapy is a sophisticated form of drug delivery for cancer. Various technologies and companies developing them are described. Nucleic acid-based cancer vaccines are also described.

Drug delivery strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples to illustrate different approaches both experimental and clinical. Biodegradable implants of carmustine are already used in the treatment of malignant brain tumors.

The market value of drug delivery technologies and the anticancer drugs are difficult to separate. Cancer market estimates from 2016-2026 are given according to organs involved and the types of cancer as well as according to technologies. Distribution of the into major regions is also described.

Profiles of 234 companies involved in developing innovative cancer therapies and methods of delivery are presented along with their 278 collaborations. The bibliography contains over 650 publications that are cited in the report.The report is supplemented with 65 tables and 13 figures.

Key Topics Covered:

Part I: Technologies & Markets

Executive Summary

1. Introduction to cancer therapy

2. Innovative treatments for cancer

3. Drug delivery systems for cancer

4. Delivery of Biological Therapies for Cancer

5. Delivery strategies according to cancer type and location

6. Cancer drug delivery markets

7. References

Part II: Companies

8. Companies involved in cancer drug delivery

For more information about this report visit https://www.researchandmarkets.com/research/kjr6wb/drug_delivery_in

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/drug-delivery-in-cancer-technologies-markets-and-companies-2016-2026-300518991.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Path Interactive Named The 2017 North America Winner Of Google's Display Innovation Award | Sep 19, 2017
Nav Telcoin announces investment by Mixi co-founder and East Ventures | Sep 19, 2017
Nav Don't Wait to Buy in the 20 Hottest Neighborhoods in the US | Sep 19, 2017
Nav Alzheimer Disease Markets, 2026: New Drugs, Markets and Companies - Profiles of 144 Companies with 92 Collaborations | Sep 19, 2017
Nav Optanix Names Mike Crest as CEO | Sep 19, 2017
Nav JMR Graphics Shares Vinyl Graphic Design Tips for Bus, Trailer, and Transit Wraps: How to Drive Big Results for Your Business | Sep 19, 2017
Nav Ibotta Launches New Performance Marketing Platform to Accelerate Traditional Retailers' Mobile Commerce Efforts | Sep 19, 2017
Nav As Innovative Video Marketing Escalates in China, Tangeche Becomes First Youku NIVA CPM Client, Powered by Mirriad Technology | Sep 19, 2017
Nav China NVH (System, Parts, Materials) Industry Report 2017-2021 Featuring 10 NVH Companies | Sep 19, 2017
Nav "Livin': From the Amsterdam Red Light to the African Bush" by Frankie Hogan Released | Sep 19, 2017
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News